blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2362866

EP2362866 - ISOPRENYL COMPOUNDS AND METHODS THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.05.2016
Database last updated on 05.07.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Signum Biosciences, Inc.
7 Deer Park Drive, Suite H
Monmouth Junction, NJ 08852 / US
[2011/36]
Inventor(s)01 / STOCK, Jeffry, B.
307 Edgerstoune Road
Princeton NJ 08540 / US
02 / STOCK, Maxwell
6 Washington Street
Rocky Hill NJ 08553 / US
03 / RAPOLE, Keshava
76 Prestwick Way
Edison NJ 08820 / US
04 / LEE, Seung-yub
2306 Stillbrook Lane
Princeton NJ 08540 / US
05 / VORONKOV, Michael
7 Blake Drive
Pennington NJ 08534 / US
06 / PEREZ, Eduardo
27 Avebury Place
Somerset NJ 08873 / US
07 / CHEN, Shuyi
1 JFK Boulevard
Apartment 29C
Somerset NJ 08873 / US
08 / CHEN, Jinglong
67 Montague Road
Newark DE 19713 / US
09 / GORDON, Joel
39 Slayback Drive
Princeton Junction NJ 08550 / US
 [2011/36]
Representative(s)ABG Intellectual Property Law, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
[N/P]
Former [2012/52]ABG Patentes, S.L.
Avenida de Burgos, 16D
Edificio Euromor
28036 Madrid / ES
Former [2011/36]Tostmann, Holger Carl, et al
Wallinger Ricker Schlotter Foerstl Patent- und Rechtsanwälte Zweibrückenstrasse 5-7
80331 München / DE
Application number, filing date09826691.911.11.2009
WO2009US64077
Priority number, dateUS20080113498P11.11.2008         Original published format: US 113498 P
[2011/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010056778
Date:20.05.2010
Language:EN
[2010/20]
Type: A1 Application with search report 
No.:EP2362866
Date:07.09.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 20.05.2010 takes the place of the publication of the European patent application.
[2011/36]
Type: B1 Patent specification 
No.:EP2362866
Date:08.07.2015
Language:EN
[2015/28]
Search report(s)International search report - published on:US20.05.2010
(Supplementary) European search report - dispatched on:EP08.06.2012
ClassificationIPC:C07C323/59, C07C335/08, C07D209/18, C07D209/48, C07D217/26, C07D307/54, C07D333/24, A61P37/02
[2012/28]
CPC:
A61K31/197 (EP,US); A61K9/0014 (US); A61P1/00 (EP);
A61P1/04 (EP); A61P11/00 (EP); A61P11/06 (EP);
A61P17/00 (EP); A61P17/04 (EP); A61P17/06 (EP);
A61P17/08 (EP); A61P25/00 (EP); A61P25/14 (EP);
A61P25/16 (EP); A61P25/28 (EP); A61P29/00 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
C07C243/34 (US); C07C321/18 (US); C07C323/59 (EP,US);
C07C335/08 (EP,US); C07D207/16 (EP,US); C07D209/18 (EP,US);
C07D209/48 (EP,US); C07D217/26 (EP,US); C07D243/34 (EP,US);
C07D295/145 (EP,US); C07D307/54 (EP,US); C07D333/24 (EP,US);
C07C2601/02 (EP,US); C07C2601/14 (EP,US) (-)
Former IPC [2011/36]C07C57/02
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2015/28]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:ISOPRENYL MITTEL UND SEIN VERFAHREN[2011/36]
English:ISOPRENYL COMPOUNDS AND METHODS THEREOF[2011/36]
French:COMPOSÉS ISOPRÉNYLÉS ET LEURS PROCÉDÉS[2011/36]
Entry into regional phase01.06.2011National basic fee paid 
01.06.2011Search fee paid 
01.06.2011Designation fee(s) paid 
01.06.2011Examination fee paid 
Examination procedure01.06.2011Examination requested  [2011/36]
04.01.2013Amendment by applicant (claims and/or description)
11.06.2013Despatch of a communication from the examining division (Time limit: M04)
27.09.2013Reply to a communication from the examining division
02.04.2014Despatch of a communication from the examining division (Time limit: M04)
12.08.2014Reply to a communication from the examining division
30.01.2015Communication of intention to grant the patent
26.05.2015Fee for grant paid
26.05.2015Fee for publishing/printing paid
26.05.2015Receipt of the translation of the claim(s)
Divisional application(s)EP15175731.7  / EP2963012
EP18150768.2  / EP3330252
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.06.2013
Opposition(s)11.04.2016No opposition filed within time limit [2016/24]
Fees paidRenewal fee
23.11.2011Renewal fee patent year 03
19.11.2012Renewal fee patent year 04
08.11.2013Renewal fee patent year 05
25.11.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.11.2009
BG08.07.2015
CY08.07.2015
CZ08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
MC08.07.2015
MK08.07.2015
MT08.07.2015
PL08.07.2015
RO08.07.2015
SI08.07.2015
SK08.07.2015
SM08.07.2015
TR08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
LU11.11.2015
[2018/30]
Former [2017/38]HU11.11.2009
BG08.07.2015
CY08.07.2015
CZ08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
MC08.07.2015
MT08.07.2015
PL08.07.2015
RO08.07.2015
SI08.07.2015
SK08.07.2015
SM08.07.2015
TR08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
LU11.11.2015
Former [2016/36]CZ08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
MC08.07.2015
PL08.07.2015
RO08.07.2015
SI08.07.2015
SK08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
LU11.11.2015
Former [2016/31]CZ08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
MC08.07.2015
PL08.07.2015
RO08.07.2015
SK08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
LU11.11.2015
Former [2016/28]CZ08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
MC08.07.2015
PL08.07.2015
RO08.07.2015
SK08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
Former [2016/23]CZ08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
PL08.07.2015
RO08.07.2015
SK08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
Former [2016/22]CZ08.07.2015
EE08.07.2015
FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
PL08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
Former [2016/10]FI08.07.2015
HR08.07.2015
LT08.07.2015
LV08.07.2015
PL08.07.2015
NO08.10.2015
GR09.10.2015
IS08.11.2015
Former [2016/09]FI08.07.2015
LT08.07.2015
LV08.07.2015
NO08.10.2015
GR09.10.2015
Former [2016/08]LT08.07.2015
NO08.10.2015
Former [2016/07]LT08.07.2015
Documents cited:Search[XP]WO2009073665  (SIGNUM BIOSCIENCES INC [US], et al) [XP] 1-12,15,17,18 * claims 4,7,15,39 * * page 31; compound 20 * * paragraphs [0024] , [0052] , [0053] , [0073] * * example 2 *;
 [X]US5043268  (STOCK JEFFRY B [US]) [X] 1,2,8-11,17,18 * claims 1,4 * * column 3, lines 16-23 *;
 [X]WO2004087064  (PURDUE RESEARCH FOUNDATION [US], et al) [X] 1,2,8-11,17,18 * claims 1,22,26 *;
 [X]  - DING J ET AL, "FARNESYL-L-CYSTEINE ANALOGS CAN INHIBIT OR INITIATE SUPEROXIDE RELEASE BY HUMAN NEUTROPHILS", JOURNAL OF BIOLOGICAL CHEMISTRY, THE AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, INC, US, (19940617), vol. 269, no. 24, ISSN 0021-9258, pages 16837 - 16844, XP001151963 [X] 1,2,8-11,17,18 * abstract * * page 16839; compounds L-PFC, L-VFC, L-BFC *
International search[X]WO2006135894  (SIGNUM BIOSCIENCES INC [US], et al);
 [Y]US5571687  (CASEY PATRICK J [US], et al);
 [Y]US5202456  (RANDO ROBERT R [US])
by applicantUS5482710
 US5202456
 US4938763
 US6432438
 US6673767
    - J. PHARMACEUTICAL SCIENCES, (1977), vol. 66, pages 1 - 19
    - Remington's Pharmaceutical Sciences, MACK PUBLISHING COMPANY OF EASTON
    - "FoxAnalytics", The Dermatology Market Outlook, B.I. LTD, (2011), page 201
    - CRANDALL, M.A., Market Intelligence Report, (2008), page 359
    - NALDI, L., CURR. DRUG TARGETS INFLAMM. ALLERGY, (2004), vol. 3, pages 121 - 128
    - NUMEROF ET AL., BIODRUGS, (2006), vol. 20, pages 93 - 103
    - MENTER ET AL., J. AM. ACAD. DERMATOL., (2009), vol. 60, pages 643 - 659
    - HORN ET AL., J. AM. ACAD. DERMATOL., (2007), vol. 57, pages 957 - 962
    - PILLA ET AL., INTL J. COSM. SCI., (2005), vol. 27, pages L7 - 34
    - TROUBA ET AL., ANTIOXID. REDOX SIGNAL, (2002), vol. 4, pages 665 - 673
    - BROWN ET AL., J AM CHEM SOC, (1991), vol. 113, pages 3176 - 3177
    - TROUTMAN ET AL., BIOCONJUGATE CHEM, (2005), vol. 16, pages 1209 - 1217
    - VAN ARMAN, C. G. ET AL., CLIN PHARMACOL THER, (1974), vol. 16, pages 900 - 4
    - YOUNG ET AL., J INVEST DERMATOL, (1983), vol. 80, pages 48 - 52
    - TRAMPOSCH ET AL., J. INVEST DERMATOL, BIRKHäUSER VERLAG: BASEL, (1999), pages 179 - 204
    - GORDON ET AL., J INVEST DERMATOL, (2008), vol. 128, pages 643 - 54
    - TRAMPOSCH ET AL., J. INVEST DERMATOL, BIRKHTäUSER VERLAG: BASEL, (1999), pages 179 - 204
    - BRADLEY ET AL., BLOOD, (1982), vol. 60, pages 618 - 22
    - GORDON ET AL., J INVEST DERM, (2008), vol. 128, pages 643 - 654
    - DENIG, N.I. ET AL., POSTGRAD MED, (1998), vol. 103, no. 199-20, pages 207 - 8,212-3
    - BRADLEY ET AL., J INVEST DERMATOL, (1982), vol. 78, pages 206 - 209
    - DE YOUNG ET AL., AGENTS ACTIONS, (1989), vol. 26, pages 335 - 41
    - RAO ET AL., INFLAMMATION, (1993), vol. 17, pages 723 - 41
    - YONG-CHEN ET AL., CYTOKINES, (2008), vol. 42, pages 145 - 151
    - BENDER ET AL., EXP DERMATOL, (2008), vol. 17, pages 752 - 60
    - SEIFFERT ET AL., J INVEST DERMATOL, (2006), vol. 126, pages 1017 - 27
    - SWERLICK ET AL., J INVEST DERMATOL, (1993), vol. 100, pages 111S - 115S
    - FALLON ET AL., NAT GENETICS, (2009), vol. 41, pages 602 - 608
    - SANO ET AL., NAT MED, (2005), vol. 11, no. 1, pages 43 - 9
    - WRONE-SMITH ET AL., J CLIN INVEST, (1996), vol. 98, pages 1878 - 1887
    - NICKOLOFF ET AL., AM JPATHOL, (1999), vol. 155, pages 145 - 158
    - SANO ET AL., NAT MED, (2005), vol. 11, pages 43 - 9
    - VOLKER ET AL., METHODS ENZYMOL, (1995), vol. 250, pages 216 - 225
    - VOLKER ET AL., METHODS, vol. 1, pages 283 - 287
    - PILLA ET AL., INTL J COSM SCI, (2005), vol. 27, pages 17 - 34
    - KESHAVARZIAN ET AL., J LAB CLIN MED, (1997), vol. 130, pages 216 - 225
    - GOLDSTEIN ET AL., J CLIN INVEST, (1975), vol. 56, pages 1155 - 63
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.